South Africa has put a hold on the rollout of the AstraZeneca COVID-19 vaccine.
Health Minister Dr Zweli Mkhize last night announced that a team of experts would give guidance on the way forward with this vaccine.
Early scientific data released on Sunday revealed that the vaccine offered “minimal protection” against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.
Clinical trial data from the AstraZeneca COVID-19 vaccine study locally revealed that it had a 22% efficacy against the 501Y.V2 coronavirus variant.
Minister Mkhize said that at the time that government acquired the vaccines, this clinical trial data had not been concluded.
More Stories
UK Concerns Over Beta Variant ‘Invalid’ – expert
ANC Promises End To Corruption, Ramaphosa Admits Party Mistakes
It Wasn’t Me – Nomia Ndlovu
NICD Reports 578 New COVID-19 Cases In SA
Health Department DG Suspended Over Digital Vibes saga
SA ‘Exits’ Third Wave – Expert
Opposition Launch Manifestos, ANC Next Up
SA Reports 967 New COVID-19 Cases
Police Clamp Down On Drunk Drivers, Suspected Criminals
SA Reports 1 634 New COVID-19 Cases
Zulu King Vows To Protect Shaka’s Legacy
Zuma Back At Nkandla – Reports